Bitfarms Ltd — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Bitfarms Ltd filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $229.28M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $133.27M | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | $120.40M | Mar 31, 2026 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($18.90M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($15.91M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | ($23.74M) | Mar 31, 2026 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($284.54M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($28.37M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | ($55.51M) | Mar 31, 2026 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($149.60M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($28.01M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | ($50.00M) | Mar 31, 2026 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($226.59M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($141.71M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | ($106.89M) | Mar 31, 2026 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.30B | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $663.13M | Mar 31, 2026 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $735.97M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $51.99M | Mar 31, 2026 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $560.38M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $611.15M | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | $325.36M | Mar 31, 2026 |
| FY2025 | Dec 31, 2022 | $246.54M | Mar 31, 2026 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($612.48M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($327.94M) | Mar 31, 2026 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $669.47M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $1.58M | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | $4.02M | Mar 31, 2026 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 31, 2026 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 31, 2026 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 601.58M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 479.33M | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | 334.15M | Mar 31, 2026 |
| FY2025 | Dec 31, 2022 | 224.20M | Mar 31, 2026 |